First-in-human Study of Orally Administered KT-579 in Healthy Adult Participants
Abroad (travel likely)RecruitingPHASE1
Conditions
Healthy Participants
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Celerion, Lincoln, Nebraska, United States